EDP-938

EDP-938 · Enanta Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for EDP-938, covering 2019-02-12 to 2026-08-19. Get the full timeline:

Most recent: Clinical Trial Results: A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. [Phase 2]